The Evidence Gap in Medical AI: Why 1,451 FDA-Cleared Devices Don't Mean 1,451 Proven Tools

A critical analysis for clinicians, researchers, and policy makers examining the disconnect between the rapid growth of FDA-authorized AI/ML medical devices and the thin evidence base supporting their clinical impact, drawing on the JAMA evidence audit, the Nature Medicine proportional evidence call, and the AMIA evaluation framework.

Tool: The Evidence Gap in Medical AI: Why 1,451 FDA-Cleared Devices Don't Mean 1,451 Proven Tools
Published: 2026-06-19
Updated: 2026-07-24

Reviewer

Not reported

FDA clearance status

Not reported

A regulatory fact, reported separately from the evidence verdict.

Risk-of-bias verdict

Not yet rated

The Adoption Surge and the Device Count

The numbers are striking. By the end of 2025, the U.S. Food and Drug Administration had authorized a cumulative total of 1,451 artificial intelligence and machine learning (AI/ML) enabled medical devices. In 2025 alone, 295 new devices received clearance — the highest annual total on record. Meanwhile, a February 2026 survey of 120 U.S. health systems by Eliciting Insights found that 75% have deployed at least one AI solution, up from 59% in 2025. Multi-solution adoption — three or more AI tools — grew 67% year-over-year, reaching 59% of surveyed systems.

These figures paint a picture of rapid, widespread integration. But they also raise a question that clinicians, researchers, and procurement teams cannot afford to ignore: does regulatory clearance equal clinical proof?

Illustration showing a stack of FDA clearance certificates on the left and a single clipboard with clinical trial documents on the right, with a broken-link gap symbol between them. — The visual contrast between regulatory clearance volume and clinical evidence depth.

Risk-of-bias scorecard

Study design: Not reported in the cited evidence
External / prospective validation: Not reported in the cited evidence
Key performance metric: Not reported in the cited evidence
Overall rating: Not yet rated

Current regulatory status

Reviewer and related appraisals

Reviewer not reported

See full reviewer directory

Informational only — read the full disclaimer. This content supports procurement and research judgment, not clinical care decisions.

Submit a correction or sourcing issue